This Apple-like Innovator is Revolutionizing Healthcare

AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.

Click here to learn more about the booming eHealth industry

RPTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 28.50%

Insider Buying (Last 12 Months): $7,479,132.40

Insider Selling (Last 12 Months): $68,485.47

Repare Therapeutics Insider Trading History Chart

Repare Therapeutics Share Price & Price History

^$3.43

▲ +0.17 (5.21%)

As of 04/23/2024 03:42 PM ET

Days: 30 | 90 | 365

Bitcoin Rockets To Record High But Buy THIS Instead

From Paradigm Press | Ad

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

Repare Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/1/2024	Lloyd Mitchell Segal	CEO	Sell	2,491	$4.63	$11,533.33	107,558
4/1/2024	Michael Zinda	EVP	Sell	410	$4.66	$1,910.60	71,908
4/1/2024	Steve Forte	CFO	Sell	789	$4.61	$3,637.29	44,775
3/27/2024	Lloyd Mitchell Segal	CEO	Sell	2,650	$4.63	$12,269.50	83,866
3/27/2024	Michael Zinda	EVP	Sell	450	$4.62	$2,079.00	72,768
3/27/2024	Steve Forte	CFO	Sell	825	$4.62	$3,811.50	42,212
3/25/2024	Lloyd Mitchell Segal	CEO	Sell	2,650	$4.79	$12,693.50	89,166
3/25/2024	Michael Zinda	EVP	Sell	450	$4.78	$2,151.00	73,668
3/25/2024	Steve Forte	CFO	Sell	825	$4.79	$3,951.75	43,862
11/15/2023	Bvf Partners L P/Il	Major Shareholder	Buy	931,556	$5.00	$4,657,780.00	5,155,739
11/2/2023	Bvf Partners L P/Il	Major Shareholder	Buy	783,709	$3.60	$2,821,352.40	4,662,402
6/6/2023	Michael Zinda	EVP	Sell	1,200	$12.04	$14,448.00	69,391
12/9/2022	Davis Jerel	Director	Sell	250,000	$16.00	$4,000,000.00	2,094,451
6/13/2022	Bvf Partners L P/Il	Major Shareholder	Buy	149,161	$12.73	$1,898,819.53	4,443,423
6/6/2022	Bvf Partners L P/Il	Major Shareholder	Buy	6,869	$13.21	$90,739.49	4,368,757
6/3/2022	Davis Jerel	Director	Sell	750,000	$12.25	$9,187,500.00	44,065
6/2/2022	Bvf Partners L P/Il	Major Shareholder	Buy	1,186,045	$11.68	$13,853,005.60	4,011,604
5/18/2022	Bvf Partners L P/Il	Major Shareholder	Buy	420,000	$8.50	$3,570,000.00	3,350,950
1/19/2022	Bvf Partners L P/Il	Major Shareholder	Buy	997,961	$14.10	$14,071,250.10
11/16/2021	Thomas Civik	Director	Buy	7,500	$28.08	$210,600.00
11/15/2021	Michael Zinda	EVP	Sell	20,000	$27.33	$546,600.00
9/7/2021	David P. Bonita	Director	Sell	887	$33.93	$30,095.91
9/3/2021	David P. Bonita	Director	Sell	7,197	$34.00	$244,698.00
9/1/2021	Orbimed Advisors Llc	Director	Sell	12,968	$33.98	$440,652.64
8/30/2021	Orbimed Advisors Llc	Director	Sell	6,697	$33.92	$227,162.24
8/27/2021	Orbimed Advisors Llc	Director	Sell	7,093	$33.94	$240,736.42
8/25/2021	Orbimed Advisors Llc	Director	Sell	7,082	$34.34	$243,195.88
8/23/2021	Orbimed Advisors Llc	Director	Sell	7,094	$34.06	$241,621.64
8/17/2021	Orbimed Advisors Llc	Director	Sell	17,398	$34.12	$593,619.76
7/12/2021	Ansbert Gadicke	Major Shareholder	Sell	58,012	$33.59	$1,948,623.08
7/12/2021	Todd Foley	Director	Sell	25,559	$33.59	$858,526.81
7/12/2021	Todd Foley	Director	Sell	25,559	$33.59	$858,526.81
7/9/2021	Ansbert Gadicke	Major Shareholder	Sell	4,067	$33.06	$134,455.02
7/9/2021	Todd Foley	Director	Sell	1,792	$33.06	$59,243.52
6/28/2021	Ansbert Gadicke	Major Shareholder	Sell	16,500	$34.18	$563,970.00
6/28/2021	Todd Foley	Director	Sell	7,270	$34.18	$248,488.60
6/25/2021	Ansbert Gadicke	Major Shareholder	Sell	22,567	$33.51	$756,220.17
6/25/2021	Todd Foley	Director	Sell	9,943	$33.51	$333,189.93
6/23/2021	Ansbert Gadicke	Major Shareholder	Sell	1,410	$32.98	$46,501.80
6/23/2021	Todd Foley	Director	Sell	622	$32.98	$20,513.56
6/21/2021	Ansbert Gadicke	Major Shareholder	Sell	37,588	$34.50	$1,296,786.00
6/21/2021	Todd Foley	Director	Sell	16,562	$34.50	$571,389.00
6/17/2021	Ansbert Gadicke	Major Shareholder	Sell	32,518	$33.80	$1,099,108.40
6/17/2021	Todd Foley	Director	Sell	14,328	$33.80	$484,286.40
6/9/2021	Lloyd Mitchell Segal	CEO	Sell	1,576	$35.00	$55,160.00	5,000
6/9/2021	Todd Foley	Director	Sell	15,523	$34.68	$538,337.64
6/7/2021	Ansbert Gadicke	Major Shareholder	Sell	23,117	$32.68	$755,463.56
6/7/2021	Todd Foley	Director	Sell	10,186	$32.68	$332,878.48
6/4/2021	Lloyd Mitchell Segal	CEO	Sell	5,000	$31.25	$156,250.00	10,000
6/3/2021	Ansbert Gadicke	Major Shareholder	Sell	22,296	$31.92	$711,688.32
6/3/2021	Todd Foley	Director	Sell	9,824	$31.92	$313,582.08
5/26/2021	Ansbert Gadicke	Major Shareholder	Sell	24,036	$32.76	$787,419.36
5/26/2021	Todd Foley	Director	Sell	10,590	$32.76	$346,928.40
5/24/2021	Ansbert Gadicke	Major Shareholder	Sell	22,200	$34.12	$757,464.00
5/24/2021	Todd Foley	Director	Sell	9,782	$34.12	$333,761.84
5/20/2021	Ansbert Gadicke	Major Shareholder	Sell	9,957	$34.69	$345,408.33
5/20/2021	Lloyd Mitchell Segal	CEO	Sell	3,770	$35.03	$132,063.10
5/20/2021	Todd Foley	Director	Sell	4,387	$34.69	$152,185.03
5/18/2021	Ansbert Gadicke	Major Shareholder	Sell	23,404	$34.16	$799,480.64
5/18/2021	Lloyd Mitchell Segal	CEO	Sell	1,800	$35.00	$63,000.00	5,000
5/18/2021	Todd Foley	Director	Sell	10,312	$34.16	$352,257.92
5/17/2021	Michael Zinda	EVP	Sell	15,000	$32.71	$490,650.00	49,801

Bitcoin Rockets To Record High But Buy THIS Instead

From Paradigm Press | Ad

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

SEC Filings (Institutional Ownership Changes) for Repare Therapeutics (NASDAQ:RPTX)

85.09% of Repare Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Repare Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/19/2024	Sumitomo Mitsui Trust Holdings Inc.	308,449	$1.45M	0.0%	-5.4%	0.834%
2/15/2024	BVF Inc. IL	10,333,600	$75.44M	1.9%	+24.6%	24.528%
2/7/2024	Jump Financial LLC	39,603	$0.29M	0.0%	N/A	0.094%
2/6/2024	SRS Capital Advisors Inc.	10,000	$73K	0.0%	+100.0%	0.024%
1/30/2024	Vontobel Holding Ltd.	15,000	$0.11M	0.0%	N/A	0.036%
1/17/2024	ARK Investment Management LLC	2,821,560	$20.60M	0.1%	+7.7%	6.697%
1/8/2024	Harbor Capital Advisors Inc.	48,055	$0.35M	0.1%	+14.2%	0.114%
1/5/2024	Exchange Traded Concepts LLC	13,585	$99K	0.0%	+34.0%	0.032%
11/15/2023	Redmile Group LLC	2,404,695	$29.05M	1.4%	-1.0%	5.708%
11/14/2023	Blackstone Inc.	25,957	$0.31M	0.0%	+14.9%	0.062%
11/14/2023	Trexquant Investment LP	29,456	$0.36M	0.0%	-47.3%	0.070%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	14,919	$0.18M	0.0%	+30.6%	0.035%
11/13/2023	FMR LLC	1,079,847	$13.05M	0.0%	-7.6%	2.563%
10/30/2023	Sumitomo Mitsui Trust Holdings Inc.	326,011	$3.94M	0.0%	+1.1%	0.775%
10/24/2023	Raymond James Financial Services Advisors Inc.	12,357	$0.15M	0.0%	N/A	0.029%
10/20/2023	Harbor Capital Advisors Inc.	42,085	$0.51M	0.1%	+13.8%	0.100%
10/18/2023	ARK Investment Management LLC	2,620,883	$31.66M	0.2%	-0.3%	6.227%
9/21/2023	Barclays PLC	3,409	$36K	0.0%	N/A	0.008%
8/11/2023	Hershey Trust Co.	5,883	$62K	0.0%	N/A	0.014%
8/11/2023	Trexquant Investment LP	55,932	$0.59M	0.0%	-36.5%	0.133%
8/9/2023	Versant Venture Management LLC	2,646,657	$28M	33.2%	N/A	6.288%
8/8/2023	Candriam S.C.A.	50,001	$0.53M	0.0%	N/A	0.119%
8/7/2023	Acadian Asset Management LLC	81,629	$0.86M	0.0%	-3.1%	0.194%
8/2/2023	Bank of Montreal Can	117,824	$1.47M	0.0%	N/A	0.280%
7/31/2023	Sumitomo Mitsui Trust Holdings Inc.	322,616	$3.41M	0.0%	+99.6%	0.766%
7/25/2023	DekaBank Deutsche Girozentrale	40,000	$0.43M	0.0%	+174.0%	0.095%
7/20/2023	Exchange Traded Concepts LLC	11,445	$0.12M	0.0%	N/A	0.027%
7/11/2023	Harbor Capital Advisors Inc.	36,984	$0.39M	0.1%	+10.0%	0.088%
7/10/2023	ARK Investment Management LLC	2,628,073	$27.81M	0.2%	-4.0%	6.244%
5/15/2023	Sio Capital Management LLC	228,538	$2.25M	1.1%	N/A	0.543%
5/11/2023	Acadian Asset Management LLC	84,273	$0.83M	0.0%	+222.1%	0.200%
5/11/2023	CHI Advisors LLC	2,997,939	$29.50M	7.8%	+7.1%	7.124%
5/9/2023	Tower Research Capital LLC TRC	11,316	$0.11M	0.0%	+533.2%	0.027%
5/3/2023	Nikko Asset Management Americas Inc.	161,598	$1.47M	0.0%	-7.1%	0.384%
5/1/2023	Compagnie Lombard Odier SCmA	14,000	$0.14M	0.0%	N/A	0.033%
4/27/2023	Sumitomo Mitsui Trust Holdings Inc.	161,598	$1.59M	0.0%	-7.1%	0.384%
4/17/2023	ARK Investment Management LLC	2,737,324	$26.94M	0.2%	+12.7%	6.505%
2/13/2023	Nikko Asset Management Americas Inc.	174,033	$2.55M	0.0%	-7.0%	0.415%
2/10/2023	HRT Financial LP	22,529	$0.33M	0.0%	N/A	0.054%
2/8/2023	Swiss National Bank	45,500	$0.67M	0.0%	+2.7%	0.108%
2/7/2023	TD Asset Management Inc	22,758	$0.34M	0.0%	-22.2%	0.054%
2/1/2023	Bank of Montreal Can	128,827	$1.92M	0.0%	-3.8%	0.307%
1/30/2023	Sumitomo Mitsui Trust Holdings Inc.	174,033	$2.56M	0.0%	-7.0%	0.415%
1/26/2023	Dupont Capital Management Corp	12,271	$0.18M	0.0%	N/A	0.029%
1/24/2023	ARK Investment Management LLC	2,428,055	$35.72M	0.3%	-7.7%	5.786%
1/20/2023	Harbor Capital Advisors Inc.	34,572	$0.51M	0.5%	N/A	0.082%
11/15/2022	Ensign Peak Advisors Inc	90,803	$1.10M	0.0%	+6.4%	0.216%
11/14/2022	Difesa Capital Management LP	15,416	$0.19M	0.1%	N/A	0.037%
11/10/2022	Bank of Montreal Can	133,895	$1.68M	0.0%	-2.9%	0.319%
11/7/2022	TD Asset Management Inc.	29,263	$0.35M	0.0%	-15.7%	0.070%
11/7/2022	Fox Run Management L.L.C.	11,801	$0.14M	0.1%	N/A	0.028%
11/7/2022	Jump Financial LLC	18,200	$0.22M	0.0%	N/A	0.043%
10/21/2022	Sumitomo Mitsui Trust Holdings Inc.	187,037	$2.27M	0.0%	N/A	0.446%
10/17/2022	ARK Investment Management LLC	2,632,028	$31.93M	0.2%	-5.3%	6.278%
8/13/2022	Virtu Financial LLC	12,519	$0.18M	0.0%	N/A	0.030%
8/12/2022	Ensign Peak Advisors Inc	85,323	$1.19M	0.0%	-24.7%	0.204%
8/12/2022	Affinity Asset Advisors LLC	321,200	$4.49M	1.9%	-31.5%	0.766%
8/12/2022	Rafferty Asset Management LLC	67,759	$0.95M	0.0%	N/A	0.162%
8/11/2022	Trexquant Investment LP	51,227	$0.72M	0.0%	N/A	0.122%
8/11/2022	Bpifrance SA	8,055	$0.11M	0.0%	N/A	0.019%
8/11/2022	Bank of Montreal Can	137,855	$1.94M	0.0%	-0.6%	0.329%
8/11/2022	Alps Advisors Inc.	24,850	$0.35M	0.0%	N/A	0.059%
8/9/2022	Swiss National Bank	44,300	$0.62M	0.0%	+12.2%	0.106%
8/4/2022	TD Asset Management Inc.	34,708	$0.49M	0.0%	-28.5%	0.083%
8/2/2022	Bartlett & Co. LLC	2,000	$28K	0.0%	N/A	0.005%
7/11/2022	ARK Investment Management LLC	2,779,331	$25.51M	0.2%	-3.3%	6.634%
5/16/2022	Deep Track Capital LP	2,664,017	$37.94M	2.4%	+26.9%	6.359%
5/10/2022	Sectoral Asset Management Inc.	237,785	$3.39M	0.6%	+15.0%	0.568%
5/10/2022	TD Asset Management Inc.	48,530	$0.69M	0.0%	-28.5%	0.116%
5/9/2022	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	11,580	$0.17M	0.0%	+9.5%	0.028%
4/28/2022	DekaBank Deutsche Girozentrale	14,600	$0.21M	0.0%	+9.8%	0.035%
4/19/2022	ARK Investment Management LLC	2,875,315	$40.94M	0.2%	-3.5%	6.866%
2/14/2022	Virtus ETF Advisers LLC	8,355	$0.18M	0.1%	+28.9%	0.020%
2/14/2022	Redmile Group LLC	2,789,496	$58.83M	1.3%	+8.6%	6.684%
2/14/2022	Point72 Asset Management L.P.	28,500	$0.60M	0.0%	-52.3%	0.068%
2/14/2022	Deep Track Capital LP	2,100,000	$44.29M	3.1%	N/A	5.032%
2/14/2022	Affinity Asset Advisors LLC	271,778	$5.73M	2.1%	N/A	0.651%
2/11/2022	Ensign Peak Advisors Inc	92,324	$1.95M	0.0%	+375.9%	0.221%
2/11/2022	Bank of Montreal Can	138,606	$3.04M	0.0%	-9.6%	0.332%
2/10/2022	TD Asset Management Inc.	67,828	$1.43M	0.0%	+51.1%	0.163%
2/8/2022	Swiss National Bank	36,900	$0.78M	0.0%	+77.4%	0.088%
2/8/2022	Northern Trust Corp	20,991	$0.44M	0.0%	+32.6%	0.050%
2/7/2022	SG Americas Securities LLC	34,354	$0.73M	0.0%	+28.3%	0.082%
2/7/2022	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	10,578	$0.23M	0.0%	+17.8%	0.025%
1/28/2022	ARK Investment Management LLC	2,980,836	$62.87M	0.2%	+0.5%	7.142%
1/24/2022	National Bank of Canada FI	2,025	$43K	0.0%	N/A	0.005%
12/14/2021	UBS Asset Management Americas Inc.	160,499	$4.21M	0.0%	-3.3%	0.385%
11/16/2021	Millennium Management LLC	171,461	$4.50M	0.0%	+659.2%	0.462%
11/16/2021	MPM Asset Management LLC	2,242,636	$58.85M	13.6%	-1.3%	6.042%
11/16/2021	BioImpact Capital LLC	1,639,849	$43.03M	6.7%	-2.2%	4.418%
11/16/2021	CHI Advisors LLC	2,232,783	$58.59M	17.1%	-12.1%	6.016%
11/16/2021	Clough Capital Partners L P	221,879	$5.82M	0.4%	-36.3%	0.598%
11/15/2021	Point72 Asset Management L.P.	59,698	$1.57M	0.0%	N/A	0.161%
11/15/2021	Great Point Partners LLC	93,137	$2.44M	0.6%	-78.6%	0.251%
11/15/2021	HighVista Strategies LLC	36,104	$0.95M	0.6%	N/A	0.097%
11/15/2021	HarbourVest Partners LLC	12,276	$0.32M	0.0%	-16.8%	0.033%
11/15/2021	Sectoral Asset Management Inc	516,485	$13.55M	1.1%	+25.3%	1.392%
11/15/2021	Franklin Resources Inc.	298,609	$7.84M	0.0%	+237.3%	0.805%
11/12/2021	Trexquant Investment LP	14,516	$0.38M	0.0%	N/A	0.039%
11/12/2021	Renaissance Technologies LLC	16,800	$0.44M	0.0%	-17.6%	0.045%

Data available starting January 2016

Repare Therapeutics Inc., a clinical-stage precision oncology company, engages in the discovery and development of therapeutics by using its synthetic lethality approach in Canada and the United States. It uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform, to discover, validate, and build a pipeline of SL-based therapeutics that focuses on genomic instability, including DNA damage repair. The company's lead product candidate is Camonsertib (RP-3500), an oral small molecule inhibitor under Phase ½ development for the treatment of solid tumors with specific DNA damage repair-related genomic alterations. It is also developing Lunresertib (RP-6306), a PKMYT1 Inhibitor, which is under Phase 1 clinical trial for tumors with genetic alterations characterized by CCNE1 amplification; RP-1664, an oral PLK4 inhibitor, under Phase 1 clinical trial designed to harness the synthetic lethal relationship with TRIM37 amplification or overexpression in solid tumors; and RP-3467, a polymerase theta adenosinetriphosphatase (ATPase) inhibitor, a SL target associated with BRCA mutations and other genomic alterations. The company has license and collaboration agreement with Hoffmann-La Roche Inc. and F. Hoffmann-La Roche Ltd; Bristol-Myers Squibb Company; New York University; and Ono Pharmaceutical Co., as well as a clinical study and collaboration agreement with Debiopharm to explore the synthetic lethal combination of PKMYT1 and WEE1 inhibition in cancer. Repare Therapeutics Inc. was incorporated in 2016 and is headquartered in Montréal, Canada.

Today's Range

Now: $3.43

$3.24

$3.43

50 Day Range

MA: $5.20

$3.02

$7.20

52 Week Range

Now: $3.43

$2.98

$13.85

Volume

120,905 shs

Average Volume

145,433 shs

Market Capitalization

$126.91 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.57

Who are the company insiders with the largest holdings of Repare Therapeutics?: Repare Therapeutics' top insider investors include:
Bvf Partners L P/Il (Major Shareholder)
Davis Jerel (Director)
Lloyd Mitchell Segal (CEO)
Michael Zinda (EVP)
Steve Forte (CFO)
Learn More about top insider investors at Repare Therapeutics.
Who are the major institutional investors of Repare Therapeutics?: Repare Therapeutics' top institutional investors include:
Sumitomo Mitsui Trust Holdings Inc. — 0.83%
Learn More about top institutional investors of Repare Therapeutics stock.
Which institutional investors are selling Repare Therapeutics stock?: During the previous quarter, RPTX stock was sold by these institutional investors:
Sumitomo Mitsui Trust Holdings Inc.
During the last year, company insiders that have sold Repare Therapeutics company stock include:
Bvf Partners L P/Il (Major Shareholder)
Davis Jerel (Director)
Lloyd Mitchell Segal (CEO)
Learn More investors selling Repare Therapeutics stock.